-->
Google

More research urged to compare and validate genomic tests for patients with early breast cancer

Written on:October 2, 2013
Comments are closed

The European Society for Medical Oncology (ESMO) has welcomed preliminary clinical trial results that suggest genomic testing could allow many patients with early breast cancer to safely avoid chemotherapy…

Source: Medical Devices

    

Sorry, the comment form is closed at this time.